Tracking the putative biosynthetic precursors of oxygenated mycolates of Mycobacterium tuberculosis. Structural analysis of fatty acids of a mutant strain deviod of methoxy- and ketomycolates - PubMed (original) (raw)
. 2003 Feb 28;278(9):7310-9.
doi: 10.1074/jbc.M210501200. Epub 2002 Dec 6.
Affiliations
- PMID: 12473649
- DOI: 10.1074/jbc.M210501200
Free article
Tracking the putative biosynthetic precursors of oxygenated mycolates of Mycobacterium tuberculosis. Structural analysis of fatty acids of a mutant strain deviod of methoxy- and ketomycolates
Premkumar Dinadayala et al. J Biol Chem. 2003.
Free article
Abstract
Disruption of the mma4 gene (renamed hma) of Mycobacterium tuberculosis has yielded a mutant strain defective in the synthesis of both keto- and methoxymycolates, with an altered cell-wall permeability to small molecules and a decreased virulence in the mouse model of infection (Dubnau, E., Chan, J., Raynaud, C., Mohan, V. P., Lanéelle, M. A., Yu, K., Quémard, A., Smith, I., and Daffé, M. (2000) Mol. Microbiol. 36, 630-637). Assuming that the mutant would accumulate the putative precursors of the oxygenated mycolates of M. tuberculosis, a detailed structural analysis of mycolates from the hma-inactivated strain was performed using a combination of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, proton NMR spectroscopy, and chemical degradation techniques. These consisted most exclusively of alpha-mycolates, composed of equal amounts of C(76)-C(82) dicyclopropanated (alpha(1)) and of C(77)-C(79) monoethylenic monocyclopropanated (alpha(2)) mycolates, the double bond being located at the "distal" position. In addition, small amounts of cis-epoxymycolates, structurally related to alpha(2)-mycolates, was produced by the mutant strain. Complementation of the hma-inactivated mutant with the wild-type gene resulted in the disappearance of the newly identified mycolates and the production of keto- and methoxymycolates of M. tuberculosis. Introduction of the hma gene in Mycobacterium smegmatis led to the lowering of diethylenic alpha mycolates of the recipient strain and the production of keto- and hydroxymycolates. These data indicate that long-chain ethylenic compounds may be the precursors of the oxygenated mycolates of M. tuberculosis. Because the lack of production of several methyltransferases involved in the biosynthesis of mycolates is known to decrease the virulence of the tubercle bacillus, the identification of the substrates of these enzymes should help in the design of inhibitors of the growth of M. tuberculosis.
Similar articles
- Investigating the function of the putative mycolic acid methyltransferase UmaA: divergence between the Mycobacterium smegmatis and Mycobacterium tuberculosis proteins.
Laval F, Haites R, Movahedzadeh F, Lemassu A, Wong CY, Stoker N, Billman-Jacobe H, Daffé M. Laval F, et al. J Biol Chem. 2008 Jan 18;283(3):1419-1427. doi: 10.1074/jbc.M708859200. Epub 2007 Nov 15. J Biol Chem. 2008. PMID: 18006503 - Structure of a hydroxymycolic acid potentially involved in the synthesis of oxygenated mycolic acids of the Mycobacterium tuberculosis complex.
Quémard A, Lanéelle MA, Marrakchi H, Promé D, Dubnau E, Daffé M. Quémard A, et al. Eur J Biochem. 1997 Dec 15;250(3):758-63. doi: 10.1111/j.1432-1033.1997.00758.x. Eur J Biochem. 1997. PMID: 9461299 - Separation and characterization of individual mycolic acids in representative mycobacteria.
Watanabe M, Aoyagi Y, Ridell M, Minnikin DE. Watanabe M, et al. Microbiology (Reading). 2001 Jul;147(Pt 7):1825-1837. doi: 10.1099/00221287-147-7-1825. Microbiology (Reading). 2001. PMID: 11429460 - Accurate molecular mass determination of mycolic acids by MALDI-TOF mass spectrometry.
Laval F, Lanéelle MA, Déon C, Monsarrat B, Daffé M. Laval F, et al. Anal Chem. 2001 Sep 15;73(18):4537-44. doi: 10.1021/ac0105181. Anal Chem. 2001. PMID: 11575804 - Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis.
Schroeder EK, de Souza N, Santos DS, Blanchard JS, Basso LA. Schroeder EK, et al. Curr Pharm Biotechnol. 2002 Sep;3(3):197-225. doi: 10.2174/1389201023378328. Curr Pharm Biotechnol. 2002. PMID: 12164478 Review.
Cited by
- Flux balance analysis of mycolic acid pathway: targets for anti-tubercular drugs.
Raman K, Rajagopalan P, Chandra N. Raman K, et al. PLoS Comput Biol. 2005 Oct;1(5):e46. doi: 10.1371/journal.pcbi.0010046. Epub 2005 Oct 14. PLoS Comput Biol. 2005. PMID: 16261191 Free PMC article. - Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria.
Alahari A, Trivelli X, Guérardel Y, Dover LG, Besra GS, Sacchettini JC, Reynolds RC, Coxon GD, Kremer L. Alahari A, et al. PLoS One. 2007 Dec 19;2(12):e1343. doi: 10.1371/journal.pone.0001343. PLoS One. 2007. PMID: 18094751 Free PMC article. - Fragment-Based Ligand Discovery Applied to the Mycolic Acid Methyltransferase Hma (MmaA4) from Mycobacterium tuberculosis: A Crystallographic and Molecular Modelling Study.
Galy R, Ballereau S, Génisson Y, Mourey L, Plaquevent JC, Maveyraud L. Galy R, et al. Pharmaceuticals (Basel). 2021 Dec 8;14(12):1282. doi: 10.3390/ph14121282. Pharmaceuticals (Basel). 2021. PMID: 34959681 Free PMC article. - Functional reconstitution of the Mycobacterium tuberculosis long-chain acyl-CoA carboxylase from multiple acyl-CoA subunits.
Bazet Lyonnet B, Diacovich L, Gago G, Spina L, Bardou F, Lemassu A, Quémard A, Gramajo H. Bazet Lyonnet B, et al. FEBS J. 2017 Apr;284(7):1110-1125. doi: 10.1111/febs.14046. Epub 2017 Mar 19. FEBS J. 2017. PMID: 28222482 Free PMC article. - Keto-mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis.
Sambandan D, Dao DN, Weinrick BC, Vilchèze C, Gurcha SS, Ojha A, Kremer L, Besra GS, Hatfull GF, Jacobs WR Jr. Sambandan D, et al. mBio. 2013 May 7;4(3):e00222-13. doi: 10.1128/mBio.00222-13. mBio. 2013. PMID: 23653446 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases